The short version.
If you read nothing else, read this. The whole guide in a handful of bullets.
- What it is: LL-37 is a synthetic copy of the body's only cathelicidin, a natural antimicrobial peptide your immune system already makes.
- What people run it for: immune support, stubborn biofilms, gut and sinus issues, and wound and skin recovery, sometimes stacked with BPC-157 or KPV.
- Typical dose: about 100–200 mcg once daily, often five days on and two days off.
- Routes: subcutaneous injection is the standard. It is not a meaningful oral peptide.
- Cycle: short runs of roughly two to four weeks, then a break, rather than running it continuously.
- Honest caveat: almost all the evidence is laboratory and animal work on the natural peptide, not human trials of the research product. It is sold for research use only, and this is not medical advice.
Quick reference.
| Typical dose | 100–200 mcg once daily |
|---|---|
| Routes | Subcutaneous injection (standard) |
| Frequency | Once daily, often 5 days on, 2 off |
| Cycle length | ~2 to 4 weeks, then a break |
| Best for | Immune support, biofilms, gut and skin recovery |
What is LL-37?
LL-37 is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. It is a synthetic copy of a natural peptide called cathelicidin, the only one of its kind that humans produce.
Your body releases LL-37 from a larger precursor protein at sites of infection or injury, in the skin, gut, and airways. It is part of the innate immune system, the fast, general-purpose defense you are born with, rather than the slower, targeted antibody response.
The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a hormone, and not a stimulant. People reach for it because it is studied for one theme above all: helping the body defend against microbes, including the stubborn biofilms that resist ordinary antibiotics, while supporting tissue repair.
Worth saying plainly: LL-37 is not an approved medicine anywhere. It is sold strictly for research use only, and almost all of the evidence is laboratory and animal work on the natural peptide, not controlled human trials of the injectable research product. We get into what that means further down.
How it works in the body.
You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.
The core idea is that LL-37 is one of your body's own antimicrobial tools, and the research version is studied for doing the same jobs: attacking microbes, calming the inflammation around an infection, and nudging tissue to heal. It does this through a few overlapping mechanisms.
- Membrane disruption. LL-37 carries a positive charge and is drawn to the negatively charged surfaces of bacteria, where it punctures and disrupts their membranes. This is its core antimicrobial action against both gram-positive and gram-negative bugs.
- Anti-biofilm and endotoxin binding. It is studied for breaking up biofilms, the protective slime that lets bacteria resist antibiotics, and for binding bacterial endotoxin (LPS), which is part of how it dampens infection-driven inflammation.
- Repair and immune signaling. Beyond killing microbes, it helps recruit immune cells and is studied for supporting cell migration and wound closure, which is why people associate it with skin and tissue recovery.
How to take it: routes of administration.
LL-37 is an injectable peptide. It is not a meaningful oral option, so the real choice is just where you inject, and for almost everyone that is a simple subcutaneous shot. Here is the honest comparison.
| Route | Typical dose | Absorption | Best for | Difficulty |
|---|---|---|---|---|
| Subcutaneous | 100–200 mcg | Reliable, systemic | Immune and gut support | Tiny needle, easy to learn |
| Intramuscular | 100–200 mcg | High | Rarely used for LL-37 | More invasive, uncommon |
| Oral | Not practical | Very low | Not recommended | Poorly absorbed |
Subcutaneous injection
The standard route by far. A tiny insulin needle goes into the fat just under the skin, not into muscle. A simple subcutaneous shot into the belly works well, and it is far less intimidating than it sounds. Start low and rotate sites.
Intramuscular
Intramuscular injection is possible but rarely used for LL-37. The needle goes deeper and it is more uncomfortable, with no clear advantage for a systemically acting immune peptide. Most people stick to subcutaneous.
Oral
LL-37 is not a practical oral peptide. It is a peptide that does not survive digestion well, so capsule versions are not worth chasing. Stick to the injectable form.
Where to inject.
If you go this route, these are the sites people use. Rotate so no single area gets sore.
The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.
So which should a beginner pick? For almost everyone, subcutaneous is the answer: absorption is reliable, the needle is tiny, and the technique is easy to learn. Intramuscular offers no real upside here, and oral is not practical.
Reconstitution: mixing it.
LL-37 arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.
Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand, especially since LL-37 is dosed in micrograms.
- Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
- Add the water slowly, down the inside wall of the vial. A common mix is a 5 mg vial plus 2.5 mL of BAC water, which gives a concentration of 2 mg/mL.
- Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
- Store it in the fridge once mixed, and keep it out of direct light.
Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 5 mg vial mixed with 2.5 mL of BAC water gives 2 mg/mL, so a 200 mcg dose is 0.1 mL, which is 10 units on a U-100 insulin syringe, and that vial holds about 25 doses.
Dosing by goal.
There is no single official dose for LL-37, because it is not an approved medicine. What follows is the range people commonly run. The defining feature of LL-37 dosing is starting low and keeping cycles short.
Starting dose
A common starting point is about 100 mcg once daily for the first several days, to see how you tolerate it. LL-37 has dose-dependent effects, so easing in matters more here than with many peptides.
Working dose
If it is well tolerated, people typically move up to around 200 mcg once daily. Many run it five days on and two days off rather than every single day. Higher doses exist in some protocols but raise the odds of side effects.
Stacked for the gut
LL-37 is often run alongside KPV and BPC-157 for gut and biofilm goals. The LL-37 schedule stays the same; the partners are dosed on their own rhythms, but the block runs together.
Ease in at the lower end to test tolerance. LL-37 has dose-dependent effects, so this matters.
Step up only if the lower dose sits well, often five days on and two off. Run in short cycles, not indefinitely.
Cycling and timing.
A cycle just means a defined run of time on the peptide, followed by a break. For LL-37 the common pattern is a short run of roughly two to four weeks, then time off, rather than running it indefinitely.
Why not just run it forever? Mostly because the long-term human safety data does not exist yet, and because LL-37 has complex, dose-dependent effects. The cautious and widely followed approach is to run a focused short block, then stop.
- Start at the low end for the first several days before considering a step up.
- Keep the cycle short, commonly two to four weeks, often with two days off each week.
- Take a real break after a cycle before considering another. If symptoms persist, that is a conversation for a licensed provider.
Stacking LL-37.
LL-37 is often run with peptides that cover gut and tissue repair, so the immune and healing angles work together.
Gut & biofilm
The combination people reach for with stubborn gut issues in mind. LL-37 targets microbes and biofilm, KPV calms inflammation, and BPC-157 supports the gut lining and soft tissue.
View stack →Immune support
Two immune-focused peptides run together. LL-37 brings the antimicrobial and anti-biofilm angle, while Thymosin α-1 is studied for broader immune modulation. A pairing people reach for when general defense is the goal.
View stack →See full recipes, dosing, and how people run them on the stacks page.
Side effects and safety.
In the reports we see, LL-37 is generally described as well tolerated at lower doses, with side effects that tend to be mild and temporary when they show up at all. The ones people mention most often are:
- Injection-site irritation, a little redness, swelling, or a small bump, which is why rotating sites and starting low matter.
- Temporary fatigue, sometimes reported as the immune system responds early in a cycle.
- Flu-like feeling that some people describe, more likely at higher doses.
- Gut upset, occasionally reported, again more likely when the dose is pushed.
Who should be cautious.
Some people have clear reasons to be extra careful, or to avoid LL-37 entirely until they have spoken with a licensed provider.
- Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
- Autoimmune or chronic inflammatory conditions. LL-37 has been linked in research to immune signaling in conditions like psoriasis and lupus, so caution is widely advised. This is a conversation for your provider, not a forum.
- Competing athletes. As an unapproved substance, LL-37 falls under WADA's blanket S0 ban and will count as prohibited.
- Anyone on other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first.
And the universal one: whoever you are, talk to a licensed healthcare provider before starting LL-37. This guide is educational, not a substitute for personalized medical advice.
Where to buy it safely.
This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.
- Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
- Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
- Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
- Be skeptical of suspiciously cheap listings with no testing behind them.
That is exactly the comparison we put together. On our LL-37 product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.
Questions, answered straight.
Is LL-37 legal?
LL-37 is not an approved drug and is not sold for human use. The vendors we compare offer it strictly for research use only. As an unapproved substance it falls under WADA's blanket S0 ban, so competing athletes should steer clear. Rules vary by country, so check what applies where you are.
What is LL-37 actually for?
It is the body's only cathelicidin, a natural antimicrobial peptide. The research version is studied for immune support, breaking up biofilms, and gut, sinus, and skin recovery. The evidence is mostly laboratory and animal work, so treat these as what it is studied for, not proven outcomes.
How is it different from BPC-157?
BPC-157 is a repair peptide that acts mostly on tissue and the gut lining and is dosed daily in micrograms. LL-37 is an antimicrobial and immune peptide, also dosed in micrograms, that targets microbes and biofilm. They are often run together in a gut-focused stack rather than as substitutes.
How long until it works?
Effects, when present, tend to build over a short cycle rather than appearing overnight. Many people run two to four weeks before judging it. It is not an instant switch, and responses vary a lot between people.
Why start at a low dose?
LL-37 has dose-dependent effects, and higher doses are more likely to bring injection-site irritation, flu-like feelings, or gut upset. Starting around 100 mcg and only increasing if it is well tolerated is the cautious, commonly followed approach.
Does it need refrigeration?
Keep the sealed, freeze-dried vial in the fridge and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within about four weeks. Do not freeze a reconstituted vial.
How do I figure out the dose in units?
Use our calculator. Enter your vial size, how much bacteriostatic water you added, and your target dose, and it tells you exactly how many units to draw on a U-100 syringe. The dosage calculator handles the math for you.